人民币升值窗口观察！英科医疗：“大存大贷”缓解了吗？

Core Viewpoint - The article discusses the impact of exchange rate fluctuations on the financial performance of Yingke Medical, highlighting the company's financial strategies and the implications of the recent appreciation of the RMB against the USD [1][3][4]. Financial Performance - As of the end of Q3 2025, Yingke Medical's short-term borrowings increased to 16.703 billion, up nearly 6 billion from Q2 2024, with these funds primarily used for purchasing financial products [6]. - The company's cash and cash equivalents mainly consist of foreign currency deposits, with a total cash balance of approximately 11.74 billion, of which 8.13 billion is held overseas [8][9]. - For the first three quarters of 2025, Yingke Medical reported a revenue growth of only 4.6%, reaching 7.42 billion, while net profit increased by 34.47% to 924 million, but the non-recurring net profit decreased by 19.32% to 484 million [11]. Investment Strategies - Yingke Medical has adopted a "large deposit and large loan" financial strategy, benefiting from high interest rates and exchange gains from overseas dollar deposits while borrowing RMB domestically [4][6]. - The company’s investment income and fair value changes contributed significantly to its profits, but these gains are not sustainable, as acknowledged in its reports [14][15]. Exchange Rate Impact - The appreciation of the RMB and the anticipated interest rate cuts by the Federal Reserve have led to a significant increase in financial expenses for Yingke Medical, which amounted to 127 million in the first three quarters of 2025, compared to a negative 35 million in the same period last year [16]. - The exchange rate fluctuations have directly affected Yingke Medical's financial results, with exchange gains contributing 75.53 million in operating profit in H1 2024, but resulting in a loss of nearly 40 million in H1 2025 [16].